Alzheimer Disease Clinical Trial
Official title:
The Beneficial Effect of Low Level Laser Therapy Combined With Nasal Irradiation on Cognitive Function and Quality of Life in Alzheimer Anemic Elderly Patients
Alzheimer's is a type of dementia that affects memory, thinking and behavior. Symptoms eventually grow severe enough to interfere with daily tasks. this study aimed to delay the deterioration of anemic elderly condition as memory affection interfere with daily life activities and social interaction
Alzheimer's disease is the commonest cause of dementia and describes a clinical syndrome made
up of three domains. First, a neuro-psychological domain encompassing those deficits of
cognitive function such as amnesia (memory loss), aphasia (language disturbance), apraxia
(the inability to carry out motor tasks despite intact motor functions) and agnosia (the
inability to recognize people or objects despite intact sensory functions). Second, a group
of psychiatric symptoms and behavioral disturbances, which have been termed neuro-psychiatric
features, non-cognitive phenomena, or behavioral and psychological symptoms of dementia
Alzheimer's disease is substantially increased among people aged 65 years or more, with a
progressive decline in memory, thinking, language and learning capacity. Alzheimer's disease
should be differentiated from normal age-related decline in cognitive function, which is more
gradual and associated with less disability. Diabetes, hypertension, smoking, obesity, and
dyslipidemia have all been found to increase risk as well a history of brain trauma,
cerebrovascular disease, and vasculopathies.
Dementia affects approximately 5%-8% of individuals over age 65, 15%- 20% of individuals over
age 75, and 25%-50% of individuals over age 85. Alzheimer disease is the most common
dementia, accounting for 50%-75% of the total, with a greater proportion in the higher age
ranges Dementia is expensive. The financial costs of managing Alzheimer's disease are
enormous. The cost of illness is high in terms of both public and private resources. Families
and caregivers who are required to provide care and patients affected by dementia also pay a
high price in terms of their quality of life The primary goals of treatment are to maximize
the patient's ability to function in daily life, maintain quality of life, slow the
progression of symptoms, and treat depression or disruptive behaviors Low level laser therapy
is a safe, non-invasive, and non-thermal modality that is based on a strong body of research
dating back to the 1960.It involved in treating several conditions, the mechanisms of action
involve the stimulation of mitochondria by the absorption of photons in cytochrome c oxidase,
resulting in increased adenosine triphosphate production, reduced oxidative stress,
anti-inflammatory effects, and increased focal cerebral blood flow
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04079803 -
PTI-125 for Mild-to-moderate Alzheimer's Disease Patients
|
Phase 2 | |
Completed |
NCT04044495 -
Sleep, Rhythms and Risk of Alzheimer's Disease
|
N/A | |
Terminated |
NCT03052712 -
Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies
|
N/A | |
Recruiting |
NCT04520698 -
Utilizing Palliative Leaders In Facilities to Transform Care for Alzheimer's Disease
|
N/A | |
Active, not recruiting |
NCT04606420 -
Can Lifestyle Changes Reverse Early-Stage Alzheimer's Disease
|
N/A | |
Recruiting |
NCT05820919 -
Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase
|
N/A | |
Terminated |
NCT03672474 -
REGEnLIFE RGn530 - Feasibility Pilot
|
N/A | |
Completed |
NCT03430648 -
Is Tau Protein Linked to Mobility Function?
|
||
Recruiting |
NCT05557409 -
A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Alzheimer's Disease Agitation
|
Phase 3 | |
Recruiting |
NCT04522739 -
Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Alzheimer's Disease
|
Phase 4 | |
Recruiting |
NCT05288842 -
Tanycytes in Alzheimer's Disease and Frontotemporal Dementia
|
||
Recruiting |
NCT04949750 -
Efficacy of Paper-based Cognitive Training in Vietnamese Patients With Early Alzheimer's Disease
|
N/A | |
Completed |
NCT06194552 -
A Multiple Dose Study of the Safety and Pharmacokinetics of NTRX-07
|
Phase 1 | |
Completed |
NCT03239561 -
Evaluation of Tau Protein in the Brain of Participants With Alzheimer's Disease Compared to Healthy Participants
|
Early Phase 1 | |
Completed |
NCT03184467 -
Clinical Trial to Evaluate the Efficacy and Safety of GV1001 in Alzheimer Patients
|
Phase 2 | |
Active, not recruiting |
NCT03676881 -
Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
|
||
Terminated |
NCT03487380 -
Taxonomic and Functional Composition of the Intestinal Microbiome: a Predictor of Rapid Cognitive Decline in Patients With Alzheimer's Disease
|
N/A | |
Completed |
NCT05538455 -
Investigating ProCare4Life Impact on Quality of Life of Elderly Subjects With Neurodegenerative Diseases
|
N/A | |
Recruiting |
NCT05328115 -
A Study on the Safety, Tolerability and Immunogenicity of ALZ-101 in Participants With Early Alzheimer's Disease
|
Phase 1 | |
Completed |
NCT05562583 -
SAGE-LEAF: Reducing Burden in Alzheimer's Disease Caregivers Through Positive Emotion Regulation and Virtual Support
|
N/A |